Spinal Cord Stimulation (SCS) Dosing Study
Recruiting in Palo Alto (17 mi)
+9 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: MedtronicNeuro
No Placebo Group
Prior Safety Data
Approved in 3 Jurisdictions
Trial Summary
What is the purpose of this trial?
This study characterized the effects of amplitude on subject satisfaction and pain relief in subjects being treated by SCS.
Research Team
Eligibility Criteria
Inclusion Criteria
22 years of age or older
Implanted with a RestoreSensor system (for back and leg pain) for at least 1 month
Has approproate SCS settings
See 5 more
Treatment Details
Interventions
- Spinal Cord Stimulation (Device)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Spinal Cord StimulationExperimental Treatment1 Intervention
Each subject was programmed to 4 different amplitude settings: 80%, 60%, 40% and 20% of perception threshold amplitude
Spinal Cord Stimulation is already approved in Canada for the following indications:
Approved in Canada as Spinal Cord Stimulation for:
- Chronic pain
- Neuropathic pain
- Spinal cord injury pain
- Failed back surgery syndrome (FBSS)
- Adhesive arachnoiditis
- Peripheral causalgia/neuropathy
- Reflex sympathetic dystrophy (RSD)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of WisconsinMadison, WI
Arizona Pain DoctorsChandler, AZ
Georgia Pain and Wellness CenterLawrenceville, GA
Global Scientific InnovationsEvansville, IN
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
MedtronicNeuro
Lead Sponsor
Trials
72
Patients Recruited
20,900+